STUDY PROTOCOLS
Study Protocol of European Regulatory Science on Tobacco (EUREST-PLUS): Policy implementation to reduce lung disease
 
More details
Hide details
1
European Network on Smoking and Tobacco Prevention (ENSP), Brussels, Belgium
2
University of Crete (UoC), Heraklion, Greece
3
Kantar Public (TNS), Brussels, Belgium
4
Smoking or Health Hungarian Foundation (SHHF), Budapest, Hungary
5
Institut Català d’Oncologia (ICO) and Bellvitge Biomedical Research Institute (IDIBELL), Catalonia, Spain
6
School of Medicine and Health Sciences, Universitat de Barcelona, Catalonia, Spain
7
King’s College London (KCL), London, United Kingdom
8
Cancer Prevention Unit and WHO Collaborating Centre for Tobacco Control, German Cancer Research Center (DKFZ), Heidelberg, Germany
9
University of Athens (UoA), Athens, Greece
10
University of Medicine and Pharmacy ‘Grigore T. Popa’, Iasi, Romania
11
Aer Pur Romania, Bucharest, Romania
12
European Respiratory Society (ERS), Lausanne, Switzerland
13
School CAPHRI, University of Maastricht (UniMaas), Maastricht, The Netherlands
14
Health Promotion Foundation (HPF), Warsaw, Poland
15
University of Waterloo (UW), Waterloo, Canada
16
Ontario Institute for Cancer Research, Toronto, Canada
CORRESPONDING AUTHOR
Constantine I. Vardavas   

European Network on Smoking and Tobacco Prevention (ENSP), Brussels, Belgium
Publish date: 2018-08-21
 
Tob. Induc. Dis. 2018;16(Suppl 2):A2
KEYWORDS
TOPICS
*EUREST PLUS Consortium List as collaborators: European Network on Smoking and Tobacco Prevention (ENSP), Belgium: Constantine Vardavas, Andrea Glahn, Christina N. Kyriakos, Dominick Nguyen, Cornel Radu-Loghin, Polina Starchenko University of Crete (UoC), Greece: Aristidis Tsatsakis, Charis Girvalaki, Sophia Papadakis, Manolis Tzatzarakis, Alexander Vardavas Kantar Public (TNS), Belgium: Nicolas Bécuwe, Lavinia Deaconu, Sophie Goudet, Christopher Hanley, Oscar Rivière Smoking or Health Hungarian Foundation (SHHF), Hungary: Tibor Demjén, Judit Kiss, Anna Piroska Kovacs Catalan Institut of Oncology (ICO); Bellvitge Biomedical Research Institute (IDIBELL), Spain: Esteve Fernández, Yolanda Castellano, Marcela Fu, Olena Tigova, Sarah Nogueira Kings College London (KCL), United Kingdom: Ann McNeill, Katherine East, Sara C. Hitchman Cancer Prevention Unit and WHO Collaborating Centre for Tobacco Control, German Cancer Research Center (DKFZ), Germany: Ute Mons, Sarah Kahnert University of Athens (UoA), Greece: Yannis Tountas, Panagiotis Behrakis, Filippos T. Filippidis, Christina Gratziou, Paraskevi Katsaounou, Theodosia Peleki, Ioanna Petroulia, Chara Tzavara University of Medicine and Pharmacy ‘Grigore T.Popa’ Iasi, Romania: Antigona Trofor, Marius Eremia, Lucia Lotrean, Florin Mihaltan European Respiratory Society (ERS), Switzerland; Goethe University Frankfurt, Germany: Gernot Werde, Tamaki Asano, Claudia Cichon, Amy Far, Céline Genton, Melanie Jessner, Linnea Hedman, Christer Janson, Ann Lindberg, Beth Maguire, Sofia Ravara, Valérie Vaccaro, Brian Ward University of Maastricht (UniMaas), Netherlands: Marc Willemsen, Hein de Vries, Karin Hummel, Gera Nagelhout Health Promotion Foundation (HPF), Poland: Witold A. Zatoński, Aleksandra Herbeć, Kinga Janik- Koncewicz, Krzysztof Przewoźniak, Mateusz Zatoński University of Waterloo (UW); Ontario Institute for Cancer Research, Canada: Geoffrey T. Fong, Thomas Agar, Pete Driezen, Shannon Gravely, Anne C.K. Quah, Mary E. Thompson
ABSTRACT
Efforts to mitigate the devastation of tobacco-attributable morbidity and mortality in the European Union (EU) are founded on its newly adopted Tobacco Products Directive (TPD) along with the first-ever health treaty, the WHO Framework Convention on Tobacco Control (FCTC). The aim of this Horizon 2020 Project entitled European Regulatory Science on Tobacco: Policy Implementation to Reduce Lung Disease (EURESTPLUS) is to monitor and evaluate the impact of the implementation of the TPD across the EU, within the context of WHO FCTC ratification. To address this aim, EUREST-PLUS consists of four objectives: 1) To create a cohort study of 6000 adult smokers in six EU MS (Germany, Greece, Hungary, Poland, Romania, Spain) within a pre-TID vs post- TPD implementation study design; 2) To conduct secondary dataset analyses of the Special Eurobarometer on Tobacco Survey (SETS); 3) To document changes in e-cigarette product parameters (technical design, labelling/packaging and chemical composition) pre-TID vs post-TPD; and 4) To enhance innovative joint research collaborations on chronic non-communicable diseases. Through this methodological approach, EUREST-PLUS is designed to generate strong inferences about the effectiveness of tobacco control policies, as well as to elucidate the mechanisms and factors by which policy implementation translates to population impact. Findings from EUREST-PLUS have potential global implications for the implementation of innovative tobacco control policies and its impact on the prevention of lung diseases.
 
REFERENCES (36)
1.
World Health Organization. Who Report on the Global Tobacco Epidemic, 2017. World Health Organization; 2017:1-263.
 
2.
World Health Organization. The European Tobacco Control Report 2007. Copenhagen, Denmark: WHO Regional Office for Europe; 2007:16.
 
3.
Peto R, Lopez AD, Boreham J, Thun MJ. Mortality from smoking in developed countries 1950-2000. 2nd ed. Geneva; Switzerland: International Union Against Cancer (UICC); 2006.
 
4.
Tsalapati K, Vardavas CI, Athanasakis K, et al. Going up in ashes? Smoking-attributable morbidity, hospital admissions and expenditure in Greece. Eur J Public Health. 2014;24(3):477-479. doi:10.1093/eurpub/cku040
 
5.
Max W. The Financial Impact of Smoking on Health-Related Costs: A Review of the Literature. Am J Heal Promot. 2001;15(5):321-331. doi:10.4278/0890-1171-15.5.321
 
6.
Directive 2014/40/EU of the European Parliament and of the Council of 3 April 2014 on the approximation of the laws, regulations and administrative provisions of the Member States concerning the manufacture, presentation and sale of tobacco and related products and repealing Directive 2001/37/EC, OJ 2014 L 127/1. 2001. (Tobacco Products Directive)
 
7.
World Health Organization. WHO Framework Convention on tobacco control. Geneva: World Health Organization; 2003.
 
8.
HETOC. Mapping of best practices and development of testing methods and procedures for identification of characterising flavours in tobacco products. Luxembourg: Publications Office of the European Union; 2016.
 
9.
EUREST. Study on the identification of potential risks to public health associated with the use of refillable electronic cigarettes and development of technical specifications for refill mechanisms. Final Report. Potential Risks from Electronic Cigarettes & their technical Specifications in Europe (PRECISE). Luxembourg: Publications Office of the European Union; 2016.
 
10.
EUREST. Study on the assessment of available evidence on toxicity, addictiveness and attractiveness of ingredients contained in tobacco and related products on the basis of information submitted by the industry in the context of reporting obligations introduced by Directive 2001/37/EC. Final Report. Database of Industry Research on the addictive and Carcinogenic additives in Tobacco. (DIRECT). Luxembourg: Publications Office of the European Union; 2016.
 
11.
Fong GT, Cummings KM, Borland R, et al. The conceptual framework of the International Tobacco Control (ITC) Policy Evaluation Project. Tob Control. 2006;15(suppl_3):iii3-iii11. doi:10.1136/tc.2005.015438
 
12.
Becker MH. The Health Belief Model and Sick Role Behavior. Health Educ Monogr. 1974;2(4):409-419. doi:10.1177/109019817400200407
 
13.
Bandura A. Social foundations of thought and action: A social-cognitive theory. Englewood Cliffs, NJ: Prentice Hall; 1986.
 
14.
Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50(2):179-211. doi:10.1016/0749-5978(91)90020-t
 
15.
Rogers R, Prentice-Dunn S. Protection Motivation Theory. New York: Plenum; 1997:113-132
 
16.
International Agency for Research on Cancer. Effectiveness of tax and price policies for tobacco control: IARC Handbook of Cancer Prevention. Vol. 14. 2011:14.
 
17.
European Commission. Special Eurobarometer 458. Attitudes of Europeans towards tobacco and electronic cigarettes. Fieldwork March 2017. 2017:32.
 
18.
Feliu A, Filippidis FT, Joossens L, et al. Impact of tobacco control policies on smoking prevalence and quit ratios in 27 European Union countries from 2006 to 2014. Tob Control. 2018. doi:10.1136/tobaccocontrol-2017-054119
 
19.
Filippidis F, Agaku I, Vardavas C. Transition from experimentation with tobacco and nicotine products to regular smoking in Europe. Tob Induc Dis. 2018;16(1). doi:10.18332/tid/84024
 
20.
Rajani NB, Vlachantoni IT, Vardavas CI, Filippidis FT. The association between occupational secondhand smoke exposure and life satisfaction among adults in the European Union. Tob Induc Dis. 2017;15(1):19. doi:10.1186/s12971-017-0127-x
 
21.
Filippidis FT, Girvalaki C, Mechili E-A, Vardavas CI. Are political views related to smoking and support for tobacco control policies? A survey across 28 European countries. Tob Induc Dis. 2017;15:45. doi:10.1186/s12971-017-0151-x
 
22.
Filippidis FT, Laverty AA, Fernandez E, Mons U, Tigova O, Vardavas CI. Correlates of self-reported exposure to advertising of tobacco products and electronic cigarettes across 28 European Union member states. Tob Control. 2017;26(e2):e130-e133. doi:10.1136/tobaccocontrol-2016-053479
 
23.
Filippidis FT, Laverty AA, Gerovasili V, Vardavas CI. Two-year trends and predictors of e-cigarette use in 27 European Union member states. Tob Control. 2017;26(1):98-104. doi:10.1136/tobaccocontrol-2015-052771
 
24.
E-cigarette experimentation and support for tobacco control policies in the European Union. Filippidis FT, Vardavas C. 6.3 Tobacco, Smoking Control and Health Education. European Respiratory Society; 2016: PA2018. doi:10.1183/13993003.congress-2016.pa2018
 
25.
Exposure to e-cigarette advertising in the European Union. Filippidis FT, Vardavas C. 6.3 Tobacco, Smoking Control and Health Education. European Respiratory Society; 2016:PA2017. doi:10.1183/13993003.congress-2016.pa2017
 
26.
Filippidis FT, Laverty AA, Vardavas CI. Experimentation with e-cigarettes as a smoking cessation aid: a cross-sectional study in 28 European Union member states. BMJ Open. 2016;6(10):e012084. doi:10.1136/bmjopen-2016-012084
 
27.
Laverty AA, Filippidis FT, Fernandez E, Vardavas CI. E-cigarette use and support for banning e-cigarette use in public places in the European Union. Prev Med. 2017;105:10-14. doi:10.1016/j.ypmed.2017.08.007
 
28.
Laverty AA, Vardavas CI, Filippidis FT. Design and marketing features influencing choice of e-cigarettes and tobacco in the EU: Table 1. Eur J Public Health. 2016;26(5):838-841. doi:10.1093/eurpub/ckw109
 
29.
Vardavas C, Girvalaki C, Vardavas A, et al. Respiratory irritants in e-cigarette refill liquids across nine European countries: a threat to respiratory health? Eur Respir J. 2017;50(6):1701698. doi:10.1183/13993003.01698-2017
 
30.
Institute of Medicine (US) Committee for the Study of the Future of Public Health. The Future of Public Health. Washington, DC: National Academies Press; 1988. doi:10.17226/1091
 
31.
World Health Organization. WHO report on the global tobacco epidemic, 2017: monitoring tobacco use and prevention policies; Executive Summary. Geneva: World Health Organization; 2017.
 
32.
Glahn A, Kyriakos CN, Radu Loghin C, et al. Tobacco control achievements and priority areas in the WHO Europe Region: A review. Tobacco Prevention & Cessation. 2018;4(April). doi:10.18332/tpc/89925
 
33.
Eurostat. Purchasing power parities (PPPs), price level indices and real expenditures. http://appsso.eurostat.ec.euro.... Accessed November 10, 2017.
 
34.
International Monetary Fund. World Economic Outlook Database. October 2017. http://www.imf.org/external/pu.... Accessed April 2, 2018.
 
35.
Joossens L, Raw M. The tobacco control scale 2016 in Europe. Brussels: Association of European Cancer Leagues; 2016:1-30.
 
36.
Joossens L, Raw M. The tobacco control scale 2013 in Europe. Brussels: Association of European Cancer Leagues; 2014.
 
 
CITATIONS (17):
1.
Patterns of tobacco use, quit attempts, readiness to quit and selfefficacy among smokers with anxiety or depression: Findings among six countries of the EUREST-PLUS ITC Europe Surveys
Ioanna Petroulia, Christina Kyriakos, Sophia Papadakis, Chara Tzavara, Filippos Filippidis, Charis Girvalaki, Theodosia Peleki, Paraskevi Katsaounou, Ann McNeill, Ute Mons, Esteve Fernández, Tibor Demjén, Antigona Trofor, Aleksandra Herbeć, Witold Zatoński, Yannis Tountas, Geoffrey Fong, Constantine Vardavas, on consortium*
Tobacco Induced Diseases
 
2.
The purchase sources of and price paid for cigarettes in six European countries: Findings from the EUREST-PLUS ITC Europe Surveys
Tibor Demjén, Judit Kiss, Piroska Kovács, Ute Mons, Sarah Kahnert, Pete Driezen, Christina Kyriakos, Mateusz Zatoński, Krzysztof Przewoźniak, Marcela Fu, Esteve Fernández, Ann McNeill, Marc Willemsen, Yannis Tountas, Antigona Trofor, Geoffrey Fong, Constantine Vardavas, on consortium*
Tobacco Induced Diseases
 
3.
The Conceptual Model and Methods of Wave 1 ( 2016 ) of the EUREST-PLUS ITC 6 European Countries Survey
Geoffrey Fong, Mary Thompson, Christian Boudreau, Nicolas Bécuwe, Pete Driezen, Thomas Agar, Anne Quah, Witold Zatoński, Krzysztof Przewoźniak, Ute Mons, Tibor Demjén, Yannis Tountas, Antigona Trofor, Esteve Fernández, Ann McNeill, Marc Willemsen, Constantine Vardavas, on consortium*
Tobacco Induced Diseases
 
4.
Extent and correlates of self-reported exposure to tobacco advertising, promotion and sponsorship in smokers: Findings from the EUREST-PLUS ITC Europe Surveys
Sarah Kahnert, Tibor Demjén, Yannis Tountas, Antigona Trofor, Krzysztof Przewoźniak, Witold Zatoński, Esteve Fernández, Ann McNeill, Marc Willemsen, Christina Kyriakos, Geoffrey Fong, Constantine Vardavas, Ute Mons, on consortium*
Tobacco Induced Diseases
 
5.
Quitting activity and use of cessation assistance reported by smokers in eight European countries: Findings from the EUREST-PLUS ITC Europe Surveys
Karin Hummel, Gera Nagelhout, Geoffrey Fong, Constantine Vardavas, Sophia Papadakis, Aleksandra Herbeć, Ute Mons, den van, Ron Borland, Esteve Fernández, Vries de, Ann McNeill, Shannon Gravely, Krzysztof Przewoźniak, Piroska Kovacs, Antigona Trofor, Marc Willemsen, behalf consortium*
Tobacco Induced Diseases
 
6.
Cross-border purchasing of cigarettes among smokers in Six Countries of the EUREST-PLUS ITC Europe Surveys
Pete Driezen, Mary Thompson, Geoffrey Fong, Tibor Demjén, Yannis Tountas, Antigona Trofor, Krzysztof Przewoźniak, Witold Zatoński, Esteve Fernández, Ute Mons, Constantine Vardavas, on consortium*
Tobacco Induced Diseases
 
7.
Social norms towards smoking and electronic cigarettes among adult smokers in seven European Countries: Findings from the EUREST-PLUS ITC Europe Surveys
Katherine East, Sara Hitchman, Mairtin McDermott, Ann McNeill, Aleksandra Herbeć, Yannis Tountas, Nicolas Bécuwe, Tibor Demjén, Marcela Fu, Esteve Fernández, Ute Mons, Antigona Trofor, Witold Zatoński, Geoffrey Fong, Constantine Vardavas, on consortium*
Tobacco Induced Diseases
 
8.
Prevalence and correlates of different smoking bans in homes and cars among smokers in 6 Countries of the EUREST-PLUS ITC Europe Surveys
Marcela Fu, Yolanda Castellano, Olena Tigova, Christina Kyriakos, Geoffrey Fong, Ute Mons, Witold Zatoński, Thomas Agar, Anne Quah, Antigona Trofor, Tibor Demjén, Krzysztof Przewoźniak, Yannis Tountas, Constantine Vardavas, Esteve Fernández, on consortium*
Tobacco Induced Diseases
 
9.
Correlates of the support for smoke-free policies among smokers: A cross-sectional study in six European countries of the EUREST-PLUS ITC EUROPE SURVEYS
Marcela Fu, Yolanda Castellano, Olena Tigova, Ute Mons, Thomas Agar, Christina Kyriakos, Anne Quah, Geoffrey Fong, Antigona Trofor, Krzysztof Przewoźniak, Witold Zatoński, Tibor Demjén, Yannis Tountas, Constantine Vardavas*, Esteve Fernández*, on Consortium**
Tobacco Induced Diseases
 
10.
Smoking in public places in six European countries: Findings from the EUREST-PLUS ITC Europe Survey
Marcela Fu, Yolanda Castellano, Olena Tigova, Ute Mons, Thomas Agar, Christina Kyriakos, Antigona Trofor, Anne Quah, Geoffrey Fong, Krzysztof Przewoźniak, Witold Zatoński, Tibor Demjén, Yannis Tountas, Constantine Vardavas*, Esteve Fernández*, on consortium**
Tobacco Induced Diseases
 
11.
Characterising smokers of menthol and flavoured cigarettes, their attitudes towards tobacco regulation, and the anticipated impact of the Tobacco Products Directive on their smoking and quitting behaviours: The EUREST-PLUS ITC Europe Surveys
Mateusz Zatoński, Aleksandra Herbeć, Witold Zatoński, Krzysztof Przewoźniak, Kinga Janik-Koncewicz, Ute Mons, Geoffrey Fong, Tibor Demjén, Yannis Tountas, Antigona Trofor, Esteve Fernández, Ann McNeill, Marc Willemsen, Karin Hummel, Anne Quah, Christina Kyriakos, Constantine Vardavas
Tobacco Induced Diseases
 
12.
Impact of anti-smoking advertising on health-risk knowledge and quit attempts across 6 European countries from the EUREST-PLUS ITC Europe Survey
Sarah Nogueira, Ann McNeill, Marcela Fu, Christina Kyriakos, Ute Mons, Esteve Fernández, Witold Zatoński, Antigona Trofor, Tibor Demjén, Yannis Tountas, Krzysztof Przewoźniak, Anne Quah, Geoffrey Fong, Sara Hitchman, Constantine Vardavas, on consortium*
Tobacco Induced Diseases
 
13.
Secondhand exposure to e-cigarette aerosols among smokers: A cross-sectional study in six European countries of the EUREST-PLUS ITC Europe Surveys
Olena Tigova, Amalia Beladenta, Yolanda Castellano, Marcela Fu, Sarah Nogueira, Christina Kyriakos, Ute Mons, Antigona Trofor, Witold Zatoński, Krzysztof Przewoźniak, Tibor Demjén, Yannis Tountas, Anne Quah, Geoffrey Fong, Esteve Fernández, Constantine Vardavas
Tobacco Induced Diseases
 
14.
Cigarette brand loyalty among smokers in six European countries: Findings from the EUREST-PLUS ITC Europe Surveys
Sarah Nogueira, Olena Tigova, Yolanda Castellano, Ute Mons, Christina Kyriakos, Ann McNeill, Antigona Trofor, Witold Zatoński, Krzysztof Przewoźniak, Tibor Demjén, Yannis Tountas, Anne Quah, Geoffrey Fong, Marcela Fu, Constantine Vardavas, Esteve Fernández, on consortium*
Tobacco Induced Diseases
 
15.
Knowledge of the health risks of smoking and impact of cigarette warning labels among tobacco users in six European countries: Findings from the EUREST-PLUS ITC Europe Surveys
Antigona Trofor, Sophia Papadakis, Lucia Lotrean, Cornel Radu-Loghin, Marius Eremia, Florin Mihaltan, Pete Driezen, Christina Kyriakos, Ute Mons, Tibor Demjén, Sarah Nogueira, Esteve Fernández, Yannis Tountas, Krzysztof Przewoźniak, Ann McNeill, Geoffrey Fong, Constantine Vardavas, on consortium*
Tobacco Induced Diseases
 
16.
Receiving support to quit smoking and quit attempts among smokers with and without smoking related diseases: Findings from the EUREST-PLUS ITC Europe Surveys
Linnea Hedman*, Paraskevi Katsaounou*, Filippos Filippidis, Sofia Ravara, Anne Lindberg, Christer Janson, Christina Gratziou, Gernot Rohde, Christina Kyriakos, Ute Mons, Esteve Fernández, Antigona Trofor, Tibor Demjén, Krzysztof Przewoźniak, Yannis Tountas, Geoffrey Fong, Constantine Vardavas, on consortium**
Tobacco Induced Diseases
 
17.
H2020 funding for respiratory research: scaling up for the prevention and treatment of lung diseases
Constantine Vardavas, Christina Kyriakos, Esteve Fernández, Panagiotis Bamidis, Kamran Siddiqi, Niels Chavannes, der van, Gary Parker, Cornel Radu-Loghin, Brian Ward, Karim Berkouk
European Respiratory Journal
 
eISSN:1617-9625